APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Debt / NOTE 3.500% 9/1
Market price (% of par)
102.94%
Total 13F principal
$0
Principal change
-$6,000,000
Total reported market value
$0
Number of holders
0
Value change
-$7,451,400
Number of sells
1

There are no holders of APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1 as of Q4 2023.